I

Inhibikase Therapeutics, Inc.

7 employees

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Diagnostics

Health Care

Therapeutics

Date founded

2008

Funding rounds raised

Total raised

$385K

from 8 investors over 8 rounds

I

Inhibikase Therapeutics, Inc. raised $385K on September 23, 2021

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

I

Inhibikase Therapeutics, Inc. raised $100K on September 23, 2011

Investors: Georgia Research Alliance

I

Inhibikase Therapeutics, Inc. raised $150K on July 16, 2010

Investors: Georgia Research Alliance

I

Inhibikase Therapeutics, Inc. raised $50K on October 26, 2009

Investors: Georgia Research Alliance

I

Inhibikase Therapeutics, Inc. raised $50K on August 31, 2009

Investors: Georgia Research Alliance

I

Inhibikase Therapeutics, Inc. raised $25K on November 20, 2008

Investors: Georgia Research Alliance

I

Inhibikase Therapeutics, Inc. raised $56K on November 20, 2008

Investors: Georgia Research Alliance

I

Inhibikase Therapeutics, Inc. raised $25K on September 25, 2008

Investors: Georgia Research Alliance

FAQ